TimeZone (America/Los Angeles)
Engineering T Cells to Conquer Cancer
Monday, June 10, 2013 11:00:00 AM PDT - 11:45:00 AM PDT
Carl H. June, M.D., a specialist in T cell biology and lymphocyte activation at the Perelman School of Medicine, University of Pennsylvania, will discuss his groundbreaking work that has led to remarkable remissions of advanced cancer. He will focus on recent and ongoing successes in developing treatments with T cells that have been genetically engineered to target cancer. Called chimeric antigen receptor T cells (CAR T cells), these modified immune cells have proven effective at eliminating cancer in some patients, and offer great hope for this emerging strategy in cancer immunotherapy.
If you've never used Adobe Connect, get a quick overview: http://www.adobe.com/products/adobeconnect.html